Nicotine for use in e-cigarettes will soon only be available to Australians via a prescription.
This decision is an interim one made by the Therapeutic Goods Administration in the interests of supporting smoking cessation.
The proposed implementation date of the amendment to the scheduling is the beginning of June 2021.
This decision is supported by the Pharmacy Guild of Australia.
The Guild also supports the delegate’s decision to delay the implementation date in order to provide enough time for the development of resources, including professional standards and clinical guidelines, and for community pharmacies to become familiar with the supply and distribution processes.
Sponsored ContentQuality Care 2020 has landed
If you work in a community pharmacy in Australia, you are most likely familiar with the Quality Care Pharmacy Program (QCPP). Operating for more than 20 years, QCPP is the quality assurance program in place for community pharmacies around the country ensuring quality, safe and consistent professional services and consumer care.Read More
The Guild is also of the opinion that the products should be registered on the Australian Register of Therapeutic Goods to address concerns around safety and quality.
This is, however, not likely to occur before mid-year next year.